AstraZeneca (AZN) AI Analysis

AZN$178.73-3.54 -1.94%
Drug Manufacturers - GeneralMega CapHigh Quality
Compare
Market cap$277.19BEnterprise value$311.89BRevenue (TTM)$62.17BMarket positionTop 5%

Score

55
Neutral
Value
45
Quality
63
Growth
56

AstraZeneca is a mixed profile at 55/100 — Value 45, Growth 56, Quality 63. Under the hood: P/E 25.9, about 27% below its own multi-year median, plus revenue compounding ~10% annually over recent years.

AstraZeneca (AZN) AI Analysis

AZN price $178.73 -3.54 -1.94%

Ticker
AZN
Price
$178.73
Change
-3.54 -1.94%
Market cap
$277.19B
P/E
25.11
Forward P/E
16.20
Dividend yield
1.72%
Beta
0.21
Sector
Healthcare
Industry
Drug Manufacturers - General
Stocklytics score
55
Value
45
Quality
63
Growth
56

Stocklytics score rationale: value 45, quality 63, growth 56.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener